UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059778
Receipt number R000068226
Scientific Title Observational Study on Hair Follicle Cells and Gut Health in Healthy Adult Males
Date of disclosure of the study information 2025/11/16
Last modified on 2025/11/05 16:52:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational Study on Hair Follicle Cells and Gut Health in Healthy Adult Males

Acronym

Observational Study on Hair Follicle Cells and Gut Health in Healthy Adult Males

Scientific Title

Observational Study on Hair Follicle Cells and Gut Health in Healthy Adult Males

Scientific Title:Acronym

Observational Study on Hair Follicle Cells and Gut Health in Healthy Adult Males

Region

Japan


Condition

Condition

No

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

This study aims to conduct an observational study targeting healthy males aged 20 to 69 years. The study will measure hair follicle cells, analyze their health status, perform health indicator analysis using blood, urine, saliva, oral mucosa, and fecal samples, measure heart sounds and bowel sounds, and conduct various questionnaire surveys.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Height/Weight/Body Fat Percentage/BMI
2) Blood-based analysis
3) Urine-based analysis
4) Saliva-based analysis
5) Oral mucosa-based analysis
6) Fecal sample-based analysis
7) Heart sounds, bowel sounds measurement
8) GSRS questionnaire (Gastrointestinal Symptom Rating Scale)
9) Simple Stress Level Checklist (Nihon University Katsura/Murakami version)
10) OSA Sleep Questionnaire MA Version
11) Hair analysis
12) Medical interview by physician

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male

Key inclusion criteria

1) Males aged 20 years or older but under 70 years at the time of obtaining consent to participate in the study
2) Individuals who are healthy and have no chronic physical disease including skin disease.
3) Individuals with normal hair volume and no hair loss on the frontal and parietal areas.
4) Individuals whose written informed consent has been obtained.
5) Individuals judged appropriate for the study by the principal.

Key exclusion criteria

1) Individuals using medical products.
2) Individuals with symptoms such as thinning hair or alopecia.
3) Individuals with skin symptoms such as skin hypersensitivity, atopic dermatitis, seborrheic or dermatitis on the scalp.
4) Individuals with diseases such as liver, kidney, heart, lung, blood, digestive organ disorders, mental disorders, or severe anemia. Also, individuals with a history of serious medical conditions.
5) Individuals who have taken medications, including antibiotics, within the past month.
6) Individuals who have regularly used or are currently using hair growth agents, drugs, quasi-drugs, or health foods that promote hair growth within the past 3 months.
7) Individuals who are undergoing treatment or treatment related to hair growth.
8) Individuals whose BMI is over 25 kg/m2.
9) Individuals whose average weekly pure alcohol consumption exceeds 40 g/day for men.
10) Individuals who participated in other clinical studies in the past 3 months.
11) Individuals who are or whose family is engaged in functional foods or cosmetics.
12) Individuals judged inappropriate for the study by the principal.

Target sample size

51


Research contact person

Name of lead principal investigator

1st name Tatsuhiko
Middle name
Last name Hirota

Organization

Asahi Quality & Innovations, Ltd.

Division name

Core Technology Research Institute

Zip code

302-0106

Address

1-21,Midori 1-chome,Moriya-shi,Ibaraki,302-0106

TEL

0297-46-4064

Email

tatsuhiko.hirota@asahi-qi.co.jp


Public contact

Name of contact person

1st name Ryoma
Middle name
Last name Shimizu

Organization

TES Holdings Co., Ltd.

Division name

Administrative Department of Clinical Trials

Zip code

110-0015

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

TEL

+81-3-6801-8480

Homepage URL


Email

r.shimizu@tes-h.co.jp


Sponsor or person

Institute

TES Holdings Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Asahi Quality & Innovations, Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

Tel

+81-3-6240-1162

Email

jimukyoku@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 28 Day

Date of IRB

2025 Year 10 Month 30 Day

Anticipated trial start date

2025 Year 12 Month 02 Day

Last follow-up date

2025 Year 12 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Measurement of hair root cells, analysis of hair root cell health status, health indicator analysis using blood, urine, saliva, oral mucosa, and fecal samples, measurement of heart sounds and bowel sounds, and observational studies based on various questionnaire surveys.


Management information

Registered date

2025 Year 11 Month 14 Day

Last modified on

2025 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068226